WHITE PLAINS, N.Y. (August 6, 2025) – White Plains Hospital announced today its adoption of GammaTile®, an innovative treatment for patients with operable brain tumors. This cutting-edge treatment provides a single-procedure solution for tumor removal surgery and radiation therapy, thereby ensuring patients receive immediate, highly targeted treatment.
Approved by the FDA, each GammaTile has radiation sources embedded in a collagen tile that delivers a precise dose of radiation directly where it is needed. The GammaTile is placed inside the surgical cavity at the time of tumor removal, targets remaining cancer cells when they are at their lowest levels, reducing their risk of recurrence.
Unlike traditional external beam radiation therapies, which require a two- to six-week treatment delay for surgical healing – and pass radiation through healthy brain tissues – GammaTile minimizes exposure to healthy tissue, reducing the potential damage and side effects associated with traditional radiation treatments. Over time, the body naturally absorbs the collagen tile.
“Adopting GammaTile further reflects our ongoing commitment to providing patients with cutting-edge treatments that improve care and outcomes,” said Dr. Randy Stevens, Director of Radiation Oncology at White Plains Hospital. “This advanced technology offers new hope for patients dealing with the treatment challenges involved with brain tumors.”
GammaTile has shown promise in treating such brain tumors as glioblastomas – the most common and aggressive malignant brain tumors in adults – brain metastases, and recurrent meningiomas.
While clinical trials are ongoing to evaluate the potential use of GammaTile in other areas, it currently is indicated only to treat newly diagnosed malignant brain tumors and recurrent brain tumors.
About White Plains Hospital
White Plains Hospital is a proud member of the Montefiore Health System, serving as its tertiary hub of advanced care in the Hudson Valley. The Hospital is a 292-bed not-for-profit healthcare organization with the primary mission of providing exceptional acute and preventive medical care to all people who live in, work in or visit Westchester County and its surrounding areas. White Plains Hospital has outpatient medical facilities across Westchester, including multispecialty practices in Armonk, Hawthorne, Larchmont, New Rochelle, Rye Brook, Somers, Yonkers and Yorktown Heights; and Scarsdale Medical Group locations in Harrison and Scarsdale.
The Hospital is fully accredited by the Joint Commission and in 2024, it received another 5-star rating from the Centers for Medicare and Medicaid Services (CMS) — the highest distinction offered by that federal agency for the third consecutive year. In addition, the Hospital received its third Magnet® designation from the American Nurses Credentialing Center (ANCC), a distinction held by only two percent of hospitals in the country. White Plains Hospital has consistently received the Outstanding Patient Experience Award from Healthgrades®, and in 2025 was awarded an “A” Safety Grade from the Leapfrog Group for the 13th consecutive time.